Commentary: All gets better in time

[摘要] In this issue of the Journal, the Michigan Mitral Research group reports their experience with surgical treatment of rheumatic mitral disease.1 The authors considered 180 middle-aged patients (mean age 59 years) undergoing primary isolated mitral repair or replacement, the large preponderance of whom had stenotic valves, from 1997 to 2018. Midway through this period, a modification in approach took place in the direction of more-stringent selection criteria for repair in rheumatic mitral disease based on anterior leaflet assessment.

[学科分类] 心脏病和心血管学